Skip to main content
E.D. Pennsylvania· 6/18/2012

In re Flonase Antitrust Litigation

Citations

  • 284 F.R.D. 207
  • 2012 WL 2277840

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • “Resolving the allegations surrounding [defendant’s] alleged conduct in delaying generic entry will resolve issues that are ‘central to the validity of each one of the claims in one stroke.’”
  • approving the yardstick methodology and stating that the “‘yardstick’ methodology has been accepted by courts as a means to measuring damages in both indirect and direct purchaser antitrust actions”
  • “Resolving the allegations surrounding GSK’s alleged conduct in delaying generic entry will resolve issues that are central to the validity of each one of the claims in one stroke. Therefore, I find the commonality requirement satisfied here.”
  • “[Courts] have routinely observed that the inability to show injury as to a few does not defeat class certification where the plaintiffs can show widespread injury to the class.”

Source: CourtListener parenthetical corpus (CC0).

Judges: Brody

Read full opinion on CourtListener

Cited by

15 cases in this archive cite this case.

Cites

51 cases in this archive are cited by this case; the 20 most cited are listed.

Other cases with this name

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.